Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Biomarker signature for predicting tumor response to anti-CD200 therapy

Biomarker signature for predicting tumor response to anti-CD200 therapy

US Patent 11761963 · Granted Sep 19, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Protected pre-association device identification2024
Modular wearable mobile and toy accessory system2024
N-acetyl-alpha-D-glucosaminidase deficiency compositions and methods2020
Network diagnostic tool for testing and commissioning building systems2020
Sterilisation and decontamination device2015
Combined treatment with an EGFR kinase inhibitor and an agent that sensitizes tu2013
Real-time publish-subscribe system2012
Combined treatment with an EGFR kinase inhibitor and an agent that sensitizes tu2012
Real-time publish-subscribe system2011
Combined treatment with an EGFR kinase inhibitor and an agent that sensitizes tu2010
Surveillance vehicle control system1990
Proportional motor control circuit1989